NOV 17, 202658 MINS READ
L-methionine catabolism involves a complex network of enzymatic reactions that degrade or transform methionine into various metabolic intermediates. In microbial systems, particularly in Escherichia coli and Corynebacterium glutamicum, methionine catabolism is tightly regulated to balance biosynthesis and degradation 1. The primary catabolic pathway involves the conversion of L-methionine to S-adenosylmethionine (SAM) by methionine adenosyltransferase, followed by demethylation to S-adenosylhomocysteine and subsequent hydrolysis to L-homocysteine 4,5. This homocysteine can be recycled back to methionine via methionine synthases (MetE, EC 2.1.1.13, cobalamin-independent; MetH, EC 2.1.1.14, cobalamin-dependent), which utilize N(5)-methyltetrahydrofolate as a methyl donor 8. The enzyme 5,10-methylenetetrahydrofolate reductase (MetF) and serine hydroxymethyltransferase (GlyA) work synergistically to provide the necessary methyl groups for this recycling pathway 8.
Alternative catabolic routes include transamination reactions catalyzed by methionine aminotransferase (MtnV from Bacillus subtilis), which converts methionine to 4-methylthio-2-oxobutanoic acid (α-keto-methionine) 3. This α-keto acid can undergo further oxidative decarboxylation or serve as a substrate for reductive amination back to methionine via leucine dehydrogenase (LeuDH) in the presence of NADH and ammonium salts 3. The reversibility of these reactions is crucial for metabolic engineering strategies aimed at minimizing methionine catabolism during industrial fermentation.
In the context of methionine biosynthesis, catabolic enzymes such as cystathionine-γ-synthase (MetB, EC 2.5.1.48) can inadvertently contribute to by-product formation. MetB catalyzes the condensation of O-succinyl-L-homoserine with cysteine to form cystathionine, but it can also produce homolanthionine, a non-productive by-product that reduces methionine yield 4,5,7. Reducing MetB activity or eliminating its gene has been shown to prevent homolanthionine accumulation and enhance L-methionine production in engineered strains 4,5,7.
The transcriptional regulator McbR plays a pivotal role in controlling methionine catabolic and biosynthetic genes. McbR represses the expression of genes involved in methionine biosynthesis when methionine levels are sufficient, thereby creating a feedback inhibition loop 4,5,7. Disruption or attenuation of the mcbR gene relieves this repression, leading to increased methionine biosynthesis and reduced catabolism 4,5,7. This genetic modification is a cornerstone strategy in developing high-yield methionine-producing strains.
Methionine Synthases (MetE/MetH): MetE operates independently of cobalamin (vitamin B12) and is more commonly used in industrial strains due to its simpler cofactor requirements 8. MetH requires cobalamin and is typically found in organisms with access to this cofactor. Both enzymes convert L-homocysteine to L-methionine using N(5)-methyltetrahydrofolate as the methyl donor 8.
Methionine Adenosyltransferase: This enzyme catalyzes the ATP-dependent conversion of methionine to SAM, a universal methyl donor in cellular metabolism. Overexpression of this enzyme can lead to increased SAM pools but may also accelerate methionine catabolism if not balanced with biosynthetic flux 4.
Cystathionine-γ-Synthase (MetB): While primarily a biosynthetic enzyme, MetB's promiscuous activity can lead to homolanthionine formation when substrate concentrations are imbalanced. Reducing MetB activity by gene attenuation or knockout prevents this side reaction and improves methionine yield 4,5,7.
Leucine Dehydrogenase (LeuDH): This NADH-dependent enzyme catalyzes the reductive amination of α-keto acids to their corresponding L-amino acids. In methionine biosynthesis, LeuDH can convert 4-methylthio-2-oxobutanoic acid to L-methionine, providing an alternative route that bypasses traditional catabolic pathways 3. Coupling LeuDH with formate dehydrogenase for NADH regeneration enhances the efficiency of this reaction 3.
The balance between methionine biosynthesis and catabolism is governed by allosteric regulation, transcriptional control, and enzyme stability. Methionine itself acts as a feedback inhibitor of key biosynthetic enzymes, including homoserine O-acetyltransferase and aspartate kinase 4,5. This feedback inhibition is mediated by the McbR regulator, which binds methionine and represses the transcription of biosynthetic genes 4,5,7. In industrial strains, disrupting McbR or introducing leaky mutants of feedback-sensitive enzymes (e.g., MetK) can alleviate this inhibition and redirect metabolic flux toward methionine production 8.
Additionally, the availability of sulfur sources (e.g., methyl mercaptan, dimethyl disulfide) and reducing equivalents (NADH, NADPH) significantly impacts the efficiency of methionine biosynthesis and the extent of catabolic side reactions 6,15. Optimizing these parameters in fermentation media is essential for maximizing methionine yield and minimizing by-product formation.
Metabolic engineering approaches to reduce L-methionine catabolism focus on eliminating or attenuating catabolic enzymes, enhancing biosynthetic pathways, and optimizing regulatory networks. These strategies are critical for developing microbial strains capable of producing methionine at industrially relevant titers (>10 g/L) with minimal by-product accumulation 4,5,7.
MetB Deletion: Eliminating the metB gene encoding cystathionine-γ-synthase prevents the formation of homolanthionine, a major by-product in methionine fermentation 4,5,7. Strains with ΔmetB genotype exhibit significantly higher methionine yields (up to 30% improvement) compared to wild-type strains 4,5.
McbR Disruption: Deleting or attenuating the mcbR gene relieves feedback inhibition on methionine biosynthetic genes, leading to constitutive expression of enzymes such as MetE, MetH, and MetF 4,5,7. This genetic modification is often combined with MetB deletion to achieve synergistic effects on methionine production 4,5,7.
MetK Replacement: Replacing the wild-type methionine adenosyltransferase (MetK) with a leaky mutant reduces the conversion of methionine to SAM, thereby decreasing catabolic flux through the SAM pathway 8. This strategy is particularly effective in Escherichia strains where SAM-mediated catabolism is a major sink for methionine 8.
MetE/MetH Overexpression: Increasing the expression of methionine synthases enhances the conversion of homocysteine to methionine, effectively pulling metabolic flux toward biosynthesis and away from catabolism 4,8. Strains overexpressing MetE show methionine titers exceeding 15 g/L in optimized fermentation conditions 4.
MetF And GlyA Co-Expression: Co-overexpression of 5,10-methylenetetrahydrofolate reductase (MetF) and serine hydroxymethyltransferase (GlyA) ensures an adequate supply of N(5)-methyltetrahydrofolate, the methyl donor required by methionine synthases 8. This co-expression strategy increases methionine yield by 20–25% in Corynebacterium strains 8.
Leucine Dehydrogenase (LeuDH) Integration: Introducing LeuDH into methionine-producing strains enables the reductive amination of α-keto-methionine to L-methionine, providing an alternative biosynthetic route that bypasses catabolic bottlenecks 3. Coupling LeuDH with formate dehydrogenase for NADH regeneration further enhances this pathway's efficiency 3.
O-Acetyl-L-Homoserine Sulfhydrylase (OAHS) Engineering: OAHS catalyzes the conversion of O-acetyl-L-homoserine (OAHS) and methyl mercaptan to L-methionine and acetate 2,6,9. Engineering OAHS variants with higher substrate affinity and catalytic efficiency reduces the accumulation of acetate, a by-product that inhibits cell growth and methionine production 2,6. Strains expressing optimized OAHS from Corynebacterium humireducens achieve methionine yields of 18–22 g/L with acetate levels below 5 g/L 9.
Methyl Mercaptan Partial Pressure Control: Maintaining methyl mercaptan partial pressure between 10 kPa and 180 kPa in the reaction vessel optimizes the enzymatic conversion of OAHS to methionine while minimizing toxicity to microbial cells 2. This process parameter is critical for scaling up methionine production to industrial levels 2.
Acetate, a major by-product of OAHS-to-methionine conversion, can inhibit microbial growth and reduce methionine yield if not managed properly 6. Strategies to mitigate acetate accumulation include:
Acetate Assimilation Pathways: Engineering strains to overexpress acetyl-CoA synthetase or acetate kinase enables the assimilation of acetate into central carbon metabolism, reducing its inhibitory effects 6. Strains with enhanced acetate utilization pathways show 15–20% higher methionine titers compared to controls 6.
In Situ Acetate Conversion: Coupling methionine biosynthesis with acetate-consuming reactions (e.g., acetyl-CoA formation for fatty acid synthesis) in a single fermentation vessel reduces acetate accumulation and improves overall process economics 6.
Industrial L-methionine production typically employs a two-stage process: (1) fermentative production of methionine precursors (e.g., O-acetyl-L-homoserine, O-succinyl-L-homoserine) and (2) enzymatic conversion of these precursors to L-methionine using methyl mercaptan or dimethyl disulfide (DMDS) as sulfur donors 1,2,6,12,13.
In the first stage, genetically engineered microorganisms (e.g., Escherichia coli, Corynebacterium glutamicum) are cultured in defined media to accumulate methionine precursors 1,2,11,12,13. Key genetic modifications include:
Optimized fermentation conditions (e.g., pH 7.0–7.5, temperature 30–37°C, dissolved oxygen >30% saturation) yield OAHS titers of 20–30 g/L within 48–72 hours 2,11,12.
In the second stage, the fermentation broth containing OAHS is mixed with methyl mercaptan (or DMDS) and a biocatalyst (purified enzyme, whole cells, or cell lysate) expressing O-acetyl-L-homoserine sulfhydrylase or O-succinyl-L-homoserine sulfhydrylase 2,6,9,12,13. The enzymatic reaction proceeds as follows:
CH₃SH + O-acetyl-L-homoserine → L-methionine + acetate 2,6,9,12,13
CH₃SH + O-succinyl-L-homoserine → L-methionine + succinate 1,12,13
Key process parameters include:
DMDS can be used as an alternative sulfur source, offering advantages in terms of reduced toxicity and easier handling compared to methyl mercaptan 15. The enzymatic hydrogenolysis of DMDS generates methyl mercaptan in situ, which then reacts with OAHS to form methionine 15. A "one-pot" process combining DMDS, OAHS, and an organic reducing compound (e.g., dithiothreitol, cysteine) achieves 21% conversion of OAHS to methionine within 6 hours 15. Further optimization of enzyme loading, reducing agent concentration, and reaction temperature can improve conversion efficiency to >80% 15.
Recent advances have explored the use of carbon dioxide (CO₂) as a C1 building block for methionine biosynthesis, offering a sustainable alternative to traditional cyanide-based methods 1,3. The process involves:
| Org | Application Scenarios | Product/Project | Technical Outcomes |
|---|---|---|---|
| Evonik Operations GmbH | Sustainable industrial biosynthesis of L-methionine for animal feed and pharmaceutical applications, replacing traditional cyanide-based chemical synthesis routes. | MetAMINO (L-Methionine Production Platform) | CO2-based carboxylation of methional coupled with leucine dehydrogenase-catalyzed reductive amination, achieving direct L-methionine synthesis without cyanide, with formate dehydrogenase-mediated NADH regeneration enhancing conversion efficiency. |
| Evonik Degussa GmbH | Two-stage industrial fermentation processes for large-scale L-methionine production, particularly in facilities requiring efficient precursor-to-product conversion with minimized acetate accumulation. | Enzymatic L-Methionine Conversion System | Optimized methyl mercaptan partial pressure control (10-180 kPa) in enzymatic conversion of O-acetyl-L-homoserine to L-methionine, achieving >90% conversion within 6-12 hours while enabling acetate recycling through enhanced acetyl-CoA synthetase activity, reducing by-product inhibition by 15-20%. |
| BASF SE | Microbial fermentation platforms for high-yield L-methionine production in Corynebacterium glutamicum and Escherichia coli strains, targeting industrial-scale amino acid manufacturing. | MetB-Attenuated Methionine Production Strains | Deletion of metB gene encoding cystathionine-γ-synthase combined with mcbR disruption prevents homolanthionine by-product formation and relieves feedback inhibition, achieving up to 30% improvement in methionine yield with titers exceeding 15 g/L. |
| CJ Cheiljedang Corporation | Industrial fermentation and enzymatic conversion systems for cost-effective L-methionine production, particularly in integrated bioprocesses combining microbial cultivation with biocatalytic transformation. | Two-Stage L-Methionine Biosynthesis Process | Recombinant O-succinyl-L-homoserine sulfhydrylase from Pseudomonas aeruginosa and Chromobacterium violaceum with catalytic efficiency (kcat/Km) >10⁵ M⁻¹s⁻¹, enabling direct enzymatic conversion of fermentation-derived precursors to L-methionine with methyl mercaptan, achieving 20-30 g/L precursor titers within 48-72 hours. |
| Arkema France | Safer industrial L-methionine production processes requiring reduced handling risks of volatile sulfur compounds, applicable in pharmaceutical and feed-grade amino acid manufacturing facilities. | DMDS-Based L-Methionine Synthesis | One-pot enzymatic process using dimethyl disulfide (DMDS) with organic reducing compounds (dithiothreitol, cysteine) for in situ methyl mercaptan generation, achieving 21% conversion of O-acetyl-L-homoserine to L-methionine in 6 hours with reduced toxicity and improved handling safety compared to direct methyl mercaptan use. |